Karachi: Liven Pharma Limited has announced a Corporate Briefing Session to be held on November 18, 2026, at 2:30 PM via Zoom, in accordance with regulation 5.7.3 of the Pakistan Stock Exchange Regulations. The session aims to present shareholders, investors, and analysts with a comprehensive overview of the company's financial performance over the past year.

The briefing will provide an opportunity for stakeholders to gain insights into the financial health and strategic direction of Liven Pharma Limited. The session, titled "Liven Pharma Limited Corporate Briefing Session 2026," will be accessible to attendees from Islamabad, Karachi, and Tashkent.

According to information available from the Pakistan Stock Exchange (PSX), the company's initiative to conduct this session reflects its commitment to transparency and regulatory adherence.

Participants are invited to join the session via the scheduled Zoom meeting, providing a platform for direct engagement with the company's leadership. The session is expected to cover key financial indicators, performance metrics, and potential future developments concerning Liven Pharma Limited.